GeneDx company info

What does GeneDx do?
GeneDx (NASDAQ:WGS) specializes in genomic analysis and testing, offering advanced solutions to enhance patient care by deciphering complex genetic information. Its operations focus on leveraging cutting-edge genomics to facilitate early diagnosis and personalized treatment strategies, particularly for rare disorders, cancers, and neurological conditions. With a robust portfolio of projects, GeneDx aims to integrate precision medicine into routine healthcare, making in-depth genetic insights accessible to a wider patient base. Their objective is to empower clinicians with precise diagnostic tools and actionable data, thereby improving outcomes and quality of life for patients around the globe.
GeneDx  company media
Company Snapshot

Is GeneDx a public or private company?

key
Ownership
Public

How many people does GeneDx employ?

people
Employees
1,000

What sector is GeneDx in?

pie chart
Sector
Health Care

Where is the head office for GeneDx ?

location pin
Head Office
Stamford, United States

What year was GeneDx founded?

founded flag
Year Founded
2017
What does GeneDx specialise in?
/Genetic Testing /Diagnostic Services /Genomic Analysis /Rare Disorder /Clinical Consultation /Research Collaboration

What are the products and/or services of GeneDx ?

Overview of GeneDx offerings
Whole Exome Sequencing (WES) - Offers detailed analysis of all protein-coding genes to diagnose rare genetic conditions.
Genetic Counseling Services - Provides personalized counseling on genetic testing results and implications.
Prenatal Screening Tests - Early detection options for chromosomal abnormalities in fetuses.
Custom Panel Testing - Tailored genetic tests for specific conditions or families' unique genetic concerns.
Carrier Screening - Assesses individuals' or couples' risk of passing genetic conditions to offspring.
Cancer Genetics Testing - Identifies inherited cancer risks and guides personalized treatment plans.

Who is in the executive team of GeneDx ?

GeneDx leadership team
  • Ms. Katherine A. Stueland
    Ms. Katherine A. Stueland
    President, CEO & Director
  • Mr. Kevin  Feeley
    Mr. Kevin Feeley
    Chief Financial Officer
  • Ms. Karen  Ponchner
    Ms. Karen Ponchner
    Senior VP & Head of Operations
  • Mr. Eric  Olivares Ph.D.
    Mr. Eric Olivares Ph.D.
    Chief Product & Technology Officer
  • Mr. Devin K. Schaffer J.D., M.B.A.
    Mr. Devin K. Schaffer J.D., M.B.A.
    General Counsel
  • Mr. Paul  Kruszka M.D.
    Mr. Paul Kruszka M.D.
    Chief Medical Officer
  • Ms. Melanie  Duquette
    Ms. Melanie Duquette
    Chief Growth Officer
  • Sabrina  Dunbar
    Sabrina Dunbar
    Chief of Staff